Logo image of ELA

ENVELA CORP (ELA) Stock Fundamental Analysis

NYSEARCA:ELA - US29402E1029 - Common Stock

7.36 USD
-0.21 (-2.77%)
Last: 8/27/2025, 12:19:34 PM
Fundamental Rating

7

ELA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. ELA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ELA is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make ELA a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year ELA was profitable.
ELA had a positive operating cash flow in the past year.
Each year in the past 5 years ELA has been profitable.
Each year in the past 5 years ELA had a positive operating cash flow.
ELA Yearly Net Income VS EBIT VS OCF VS FCFELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

With an excellent Return On Assets value of 10.31%, ELA belongs to the best of the industry, outperforming 83.74% of the companies in the same industry.
With a decent Return On Equity value of 14.77%, ELA is doing good in the industry, outperforming 72.36% of the companies in the same industry.
ELA has a better Return On Invested Capital (11.43%) than 80.49% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ELA is in line with the industry average of 11.94%.
Industry RankSector Rank
ROA 10.31%
ROE 14.77%
ROIC 11.43%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ELA Yearly ROA, ROE, ROICELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

ELA has a Profit Margin of 4.30%. This is in the better half of the industry: ELA outperforms 74.80% of its industry peers.
In the last couple of years the Profit Margin of ELA has grown nicely.
ELA has a Operating Margin of 5.18%. This is in the better half of the industry: ELA outperforms 69.92% of its industry peers.
ELA's Operating Margin has improved in the last couple of years.
ELA has a Gross Margin of 23.68%. This is in the lower half of the industry: ELA underperforms 73.17% of its industry peers.
ELA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.18%
PM (TTM) 4.3%
GM 23.68%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
ELA Yearly Profit, Operating, Gross MarginsELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELA is creating some value.
ELA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ELA has been reduced compared to 5 years ago.
Compared to 1 year ago, ELA has an improved debt to assets ratio.
ELA Yearly Shares OutstandingELA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ELA Yearly Total Debt VS Total AssetsELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ELA has an Altman-Z score of 8.55. This indicates that ELA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ELA (8.55) is better than 97.56% of its industry peers.
The Debt to FCF ratio of ELA is 1.73, which is an excellent value as it means it would take ELA, only 1.73 years of fcf income to pay off all of its debts.
ELA has a Debt to FCF ratio of 1.73. This is in the better half of the industry: ELA outperforms 78.05% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ELA is not too dependend on debt financing.
ELA has a better Debt to Equity ratio (0.17) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.73
Altman-Z 8.55
ROIC/WACC1.23
WACC9.3%
ELA Yearly LT Debt VS Equity VS FCFELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

ELA has a Current Ratio of 4.58. This indicates that ELA is financially healthy and has no problem in meeting its short term obligations.
ELA has a better Current ratio (4.58) than 96.75% of its industry peers.
A Quick Ratio of 2.36 indicates that ELA has no problem at all paying its short term obligations.
ELA has a Quick ratio of 2.36. This is amongst the best in the industry. ELA outperforms 93.50% of its industry peers.
Industry RankSector Rank
Current Ratio 4.58
Quick Ratio 2.36
ELA Yearly Current Assets VS Current LiabilitesELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.50% over the past year.
The Earnings Per Share has been growing by 20.12% on average over the past years. This is a very strong growth
The Revenue has grown by 25.43% in the past year. This is a very strong growth!
The Revenue has been growing by 17.07% on average over the past years. This is quite good.
EPS 1Y (TTM)37.5%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%83.33%
Revenue 1Y (TTM)25.43%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.15%

3.2 Future

Based on estimates for the next years, ELA will show a very strong growth in Earnings Per Share. The EPS will grow by 24.07% on average per year.
The Revenue is expected to grow by 10.18% on average over the next years. This is quite good.
EPS Next Y39.99%
EPS Next 2Y24.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.32%
Revenue Next 2Y10.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ELA Yearly Revenue VS EstimatesELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ELA Yearly EPS VS EstimatesELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.30, ELA is valued on the expensive side.
70.73% of the companies in the same industry are more expensive than ELA, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.08, ELA is valued at the same level.
ELA is valuated rather expensively with a Price/Forward Earnings ratio of 19.13.
61.79% of the companies in the same industry are more expensive than ELA, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ELA to the average of the S&P500 Index (22.67), we can say ELA is valued inline with the index average.
Industry RankSector Rank
PE 22.3
Fwd PE 19.13
ELA Price Earnings VS Forward Price EarningsELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

ELA's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ELA is valued a bit cheaper than the industry average as 68.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.38
EV/EBITDA 15.52
ELA Per share dataELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ELA's earnings are expected to grow with 24.07% in the coming years.
PEG (NY)0.56
PEG (5Y)1.11
EPS Next 2Y24.07%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ELA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVELA CORP

NYSEARCA:ELA (8/27/2025, 12:19:34 PM)

7.36

-0.21 (-2.77%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners13.65%
Inst Owner Change7.3%
Ins Owners49.42%
Ins Owner Change0.31%
Market Cap191.14M
Analysts80
Price Target10.2 (38.59%)
Short Float %3.62%
Short Ratio4.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)54.5%
Min EPS beat(2)41.44%
Max EPS beat(2)67.56%
EPS beat(4)4
Avg EPS beat(4)44.08%
Min EPS beat(4)18.81%
Max EPS beat(4)67.56%
EPS beat(8)6
Avg EPS beat(8)21.46%
EPS beat(12)8
Avg EPS beat(12)27.4%
EPS beat(16)12
Avg EPS beat(16)29.08%
Revenue beat(2)2
Avg Revenue beat(2)9.1%
Min Revenue beat(2)2.14%
Max Revenue beat(2)16.06%
Revenue beat(4)4
Avg Revenue beat(4)14.28%
Min Revenue beat(4)2.14%
Max Revenue beat(4)21.16%
Revenue beat(8)6
Avg Revenue beat(8)5.22%
Revenue beat(12)9
Avg Revenue beat(12)5.09%
Revenue beat(16)12
Avg Revenue beat(16)8.2%
PT rev (1m)5.26%
PT rev (3m)25%
EPS NQ rev (1m)0.79%
EPS NQ rev (3m)-20%
EPS NY rev (1m)8.28%
EPS NY rev (3m)8.28%
Revenue NQ rev (1m)1.18%
Revenue NQ rev (3m)24.97%
Revenue NY rev (1m)6.33%
Revenue NY rev (3m)6.33%
Valuation
Industry RankSector Rank
PE 22.3
Fwd PE 19.13
P/S 0.96
P/FCF 25.38
P/OCF 17.52
P/B 3.31
P/tB 3.79
EV/EBITDA 15.52
EPS(TTM)0.33
EY4.48%
EPS(NY)0.38
Fwd EY5.23%
FCF(TTM)0.29
FCFY3.94%
OCF(TTM)0.42
OCFY5.71%
SpS7.64
BVpS2.22
TBVpS1.94
PEG (NY)0.56
PEG (5Y)1.11
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 14.77%
ROCE 14.62%
ROIC 11.43%
ROICexc 16.93%
ROICexgc 20.06%
OM 5.18%
PM (TTM) 4.3%
GM 23.68%
FCFM 3.8%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ROICexc(3y)17.69%
ROICexc(5y)18.43%
ROICexgc(3y)21.62%
ROICexgc(5y)22.7%
ROCE(3y)16.14%
ROCE(5y)17.45%
ROICexcg growth 3Y-9.57%
ROICexcg growth 5Y-0.97%
ROICexc growth 3Y-7.64%
ROICexc growth 5Y1.09%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
F-Score7
Asset Turnover2.4
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.73
Debt/EBITDA 0.8
Cap/Depr 192.86%
Cap/Sales 1.7%
Interest Coverage 26.86
Cash Conversion 90.66%
Profit Quality 88.29%
Current Ratio 4.58
Quick Ratio 2.36
Altman-Z 8.55
F-Score7
WACC9.3%
ROIC/WACC1.23
Cap/Depr(3y)141.77%
Cap/Depr(5y)313.83%
Cap/Sales(3y)1.17%
Cap/Sales(5y)2.18%
Profit Quality(3y)69.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%83.33%
EPS Next Y39.99%
EPS Next 2Y24.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.43%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.15%
Revenue Next Year18.32%
Revenue Next 2Y10.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.97%
EBIT growth 3Y-4.94%
EBIT growth 5Y20.28%
EBIT Next Year58.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.33%
OCF growth 3Y53.73%
OCF growth 5YN/A